The Impact of Treatment with IL-17/IL-23 Inhibitors on Subclinical Atherosclerosis in Patients with Plaque Psoriasis and/or Psoriatic Arthritis: A Systematic Review

Autor: Aikaterini Tsiogka, Stamatios Gregoriou, Alexander Stratigos, Stergios Soulaidopoulos, Natalia Rompoti, Pantelis Panagakis, Marina Papoutsaki, Panagiotis Kostakis, George Kontochristopoulos, Konstantinos Tsioufis, Anna Campanati, Annamaria Offidani, Charalambos Vlachopoulos, Dimitrios Rigopoulos

Publikováno v: Biomedicines, Vol 11, Iss 2, p 318 (2023)

Accumulating evidence considers psoriasis a systemic inflammatory disorder that is associated with comorbidities such as psoriatic arthritis, cardiovascular disease, and metabolic syndrome. Although the precise pathogenetic links between psoriasis an

Externí odkaz: https://doaj.org/article/bc44f5e012284ec685b8f8fd9701d048

Real world experience of brodalumab treatment in patients with moderate-to-severe plaque psoriasis in the Greek population: Results from an interim analysis of the BrIDGE study

Autor: Dimitrios, Rigopoulos, Charalampos, Angelakopoulos, Zoi, Apalla, Sophia, Georgiou, Florentina, Delli, Alexandros, Drosos, Efterpi, Zafiriou, John, Katsantonis, Elisavet, Lazaridou, Pantelis, Panagakis, Evangelia, Papadavid, Markos, Papakonstantis, Angeliki-Viktoria, Roussaki-Schulze, Elena, Sotiriou, Georgios, Anastasiadis, Eleftheria, Tampouratzi, Vasiliki, Chasapi, Konstantinos, Sfaelos, Dimitrios, Ioannides

Publikováno v: Dermatologic therapyREFERENCES. 35(12)

Brodalumab's clinical efficacy and favorable safety profile have been demonstrated during controlled clinical trials, but real-world data remain scarce. BrIDGE, an ongoing 104 week, observational, prospective, multicenter study conducted in Greece, e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16c741b1deb384db1e8c2a87c04d09a1
https://pubmed.ncbi.nlm.nih.gov/36184757

Patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis followed in a combined Dermatology-Rheumatology clinic: a retrospective real-world study

Autor: Kalliopi Klavdianou, Maria Stavropoulou, Pantelis Panagakis, Marina Papoutsaki, Alexandros Panagiotopoulos, Christos Koutsianas, Alexandros Stratigos, Dimitrios Rigopoulos, Dimitrios Vassilopoulos

Publikováno v: Rheumatology international. 42(6)

The aim of this study was to assess the patient characteristics, treatment patterns and disease outcomes in patients with psoriatic arthritis (PsA) referred to a combined Dermatology-Rheumatology (Derm-Rheum) Clinic. This was a retrospective study of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efd455258e60b02774f587b343c91413
https://pubmed.ncbi.nlm.nih.gov/35435445

Treatment of nail psoriasis with calcipotriol/betamethasone dipropionate foam versus pulse dye laser: an unblinded, intra‐patient, left‐to‐right prospective study

Autor: Theodora Tsironi, Dimitris Rigopoulos, Natalia Rompoti, Antonios Tsimpidakis, Pantelis Panagakis, Dorothea Polydorou, Panagiotis Kostakis, Stamatios Gregoriou, Polytimi Sidiropoulou

Publikováno v: Journal of the European Academy of Dermatology and Venereology. 34

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eeb51c26ef29a52ae9a943d92a4e2ab4
https://doi.org/10.1111/jdv.16426

Secukinumab shows significant efficacy in two patients with difficult-to-treat areas of psoriasis: a Greek experience

Autor: Pantelis Panagakis, Eftychia Platsidaki, Ioannis Marnelakis, Nikolaos Kostopoulos

Publikováno v: Platsidaki, Eftychia; Kostopoulos, Nikolaos; Marnelakis, Ioannis; & Panagakis, Pantelis. (2018). Secukinumab shows significant efficacy in two patients with difficult-to-treat areas of psoriasis: a Greek experience. Dermatology Online Journal, 24(3). Retrieved from: http://www.escholarship.org/uc/item/9w02w406

Psoriasis is one of the most frequently occurring chronic inflammatory skin diseases. There are some specialized regions of the body that are considered difficult to treat. Secukinumab is a human monoclonal immunoglobulin G antibody that blocks the i

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c6479bd7149280da0e7b3ebc42c02ac
https://doi.org/10.5070/d3243038622